Skip to main content
. 2019 Jul 19;10:1574. doi: 10.3389/fimmu.2019.01574

Figure 1.

Figure 1

Synergistic effect of three combined strategies by targeting complement/C3aR /C5aR1/IL-10 pathway and other treatment modalities. The three combined strategies were shown as follows: (1) dual blockade of complement signaling and immune checkpoint receptor PD-1; (2) complement signaling blockade and chemotherapy; (3) the clinical use of pegylated rhIL-10 with anti-PD-1 antibody.